Federspiel G, McCullough K C, Kihm U
Institut für Viruskrankheiten und Immunprophylaxe (IVI), Basel, Switzerland.
J Immunol Methods. 1991 Dec 15;145(1-2):71-81. doi: 10.1016/0022-1759(91)90312-4.
Splenocytes from non-immune mice were stimulated in vitro using a kit of cytokine preparations (obtained from murine MLR and EL-4 cell cultures), and concomitantly immunized with African swine fever (ASF) virus antigen. In addition, fusions were performed at 5 days after primary or secondary stimulation/immunization. The detection of specific antibodies in the culture supernatants was not successful. In contrast, specific antibody-producing hybridomas could be generated, and this was at least comparable to a standard in vivo immunization regime, even though the optimum fusion ratio employed with these in vitro immunized splenocytes was one which is not optimum when in vivo immunized lymphocytes are used. Consequently, it would appear that hybridoma generation is a more sensitive method than the direct measurement of antibody at detecting in vitro primary immune responses. After primary in vitro immunization, the majority of immunoglobulins produced were apparently of the IgG isotype, with only 8-17% clearly IgM. These antibodies were mainly against VP73 (the major viral envelope protein) as expressed on viral antigen extracted from infected cells, although other specificities were also found. This demonstrated, by in vitro means, that the VP73 carried dominant immunogenic epitopes on ASF virus. Such observations show that the in vitro responses were closely related to those which have been detected in vivo.
使用一组细胞因子制剂(从鼠混合淋巴细胞反应和EL-4细胞培养物中获得)在体外刺激非免疫小鼠的脾细胞,并同时用非洲猪瘟(ASF)病毒抗原进行免疫。此外,在初次或二次刺激/免疫后5天进行细胞融合。在培养上清液中未能成功检测到特异性抗体。相比之下,可以产生特异性抗体分泌杂交瘤,并且这至少与标准的体内免疫方案相当,尽管用于这些体外免疫脾细胞的最佳融合比例在使用体内免疫淋巴细胞时并非最佳。因此,在检测体外初次免疫反应时,杂交瘤生成似乎是一种比直接测量抗体更敏感的方法。体外初次免疫后,产生的大多数免疫球蛋白显然是IgG同种型,只有8-17%明显是IgM。这些抗体主要针对从感染细胞中提取的病毒抗原上表达的VP73(主要病毒包膜蛋白),不过也发现了其他特异性。这通过体外方法证明,VP73在ASF病毒上携带主要免疫原性表位。这些观察结果表明,体外反应与体内检测到的反应密切相关。